/Investor DB

Cross-Border Impact Ventures — 2024 Investments

1 investments dated 2024 · listed companies and verified rows first · show all

Axena Healthaxenahealth.cominJun 2024

Axena Health develops digital therapeutic devices for women's pelvic health, specifically treating urinary and fecal incontinence through at-home pelvic floor muscle training.

Digital HealthFemTechHealthtechMedical DevicesAuburndale, US

Samantha Pulliam(CEO and Chief Medical Officer)inVincent Ricci(Executive Officer)Jim O'Connor(Executive Officer)inShacey Petrovic(Executive Officer, Director)inEileen Maus(Executive Officer, Director)in

BoardJonathan Dean(Director)

Co-investorsAvestria VenturesCatalio Capital Management, LPSolas BioVentures

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.